Marché de l’acide hyaluronique au Moyen-Orient et en Afrique – Tendances et prévisions de l’industrie jusqu’en 2030

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché de l’acide hyaluronique au Moyen-Orient et en Afrique – Tendances et prévisions de l’industrie jusqu’en 2030

  • Pharmaceutical
  • Publish Reports
  • Jan 2023
  • MEA
  • 350 Pages
  • Nombre de tableaux : 300
  • Nombre de figures : 39

Middle East And Africa Hyaluronic Acid Market

Taille du marché en milliards USD

TCAC :  % Diagram

Chart Image USD 263.81 Million USD 409.69 Million 2022 2030
Diagram Période de prévision
2023 –2030
Diagram Taille du marché (année de référence)
USD 263.81 Million
Diagram Taille du marché (année de prévision)
USD 409.69 Million
Diagram TCAC
%
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>

>Marché de l'acide hyaluronique au Moyen-Orient et en Afrique - Par qualité (qualité cosmétique et qualité pharmaceutique), type (acide hyaluronique hydrolysé, acide hyaluronique acétylé de sodium et hyaluronate de sodium), application (esthétique, arthrose, API pharmaceutique, cosmétiques , ophtalmologie et autres), utilisateur final (spas médicaux et centres de beauté, cliniques de dermatologie et centres de chirurgie esthétique), canal de distribution (appels d'offres directs et ventes au détail) Tendances de l'industrie et prévisions jusqu'en 2030.

Hyaluronic Acid Market

Analyse et perspectives du marché de l'acide hyaluronique au Moyen-Orient et en Afrique

L'acide hyaluronique est principalement utilisé dans les produits de beauté et de soins de la peau. Il permet une guérison rapide des plaies, réduit les rides et le vieillissement de la peau, et guérit les coupures et les brûlures, entre autres. Il contient de la vitamine C pour éclaircir le teint. Les produits de beauté contenant de l'acide hyaluronique nourrissent la peau lorsqu'ils sont appliqués sous forme d'hydratants, de crèmes, de toniques pour la peau et de sérums, entre autres.

Hyaluronic Acid Market

Hyaluronic Acid Market

Data Bridge Market Research analyse que le marché de l'acide hyaluronique au Moyen-Orient et en Afrique croît avec un TCAC de 5,7 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 409,69 millions USD d'ici 2030 contre 263,81 millions USD en 2022.

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable pour 2020-2016)

Unités quantitatives

Chiffre d'affaires en millions USD

Segments couverts

Par catégorie (qualité cosmétique et qualité pharmaceutique), type (acide hyaluronique hydrolysé, acide hyaluronique acétylé de sodium et hyaluronate de sodium), application (esthétique, arthrose, API pharmaceutique, cosmétiques, ophtalmologie et autres), utilisateur final (spas médicaux et centres de beauté, cliniques de dermatologie et centres de chirurgie esthétique), canal de distribution (appel d'offres direct et vente au détail).

Pays couverts

Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l’Afrique.

Acteurs du marché couverts

Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals détenue par Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services et Brickell Men's Products, entre autres

Définition du marché

L'acide hyaluronique (AH), également appelé hyaluronane, est un glycosaminoglycane anionique non sulfaté largement distribué dans les tissus conjonctifs, épithéliaux et nerveux. Composant essentiel du cartilage articulaire, l'acide hyaluronique entoure chaque cellule du cartilage comme un manteau (chondrocyte). La robustesse du cartilage est due à l'ingestion d'eau par ces agrégats (sa résistance à la compression). Le poids moléculaire (taille) de l'acide hyaluronique dans le cartilage diminue avec l'âge, mais la quantité augmente. Le corps humain contient naturellement de l'AH. Les plus grandes quantités d'AH sont observées dans les articulations et les yeux. Le produit chimique a la capacité de maintenir une peau pulpeuse et hydratée. Par conséquent, il est utilisé par de nombreux chirurgiens esthétiques comme produit injectable pour retarder les signes de vieillissement de la peau.

La prévalence croissante des procédures mini-invasives et la sensibilisation et la demande croissantes d'acide hyaluronique dans les produits pharmaceutiques et cosmétiques à travers le monde sont des facteurs majeurs de croissance du marché au cours de la période de prévision. L'augmentation spectaculaire de la qualité de la recherche, associée à l'augmentation des opportunités de recherche, est due à diverses initiatives stratégiques prises par les acteurs du marché. Ils prennent des initiatives telles que des lancements de produits, des collaborations, des fusions, des acquisitions et bien d'autres au fil des ans et devraient être à la pointe et créer davantage d'opportunités sur le marché.

Dynamique du marché de l'acide hyaluronique au Moyen-Orient et en Afrique

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :

CONDUCTEURS

  • Sensibilisation accrue aux injections cosmétiques ou aux produits de comblement dermique

Les produits de comblement dermique à base d'acide hyaluronique sont les procédés cosmétiques les moins invasifs. Les problèmes dermatologiques sont courants dans le monde entier. Il est devenu une préoccupation majeure de comprendre les produits permettant de traiter les problèmes liés à la peau et de restaurer les rides cutanées. Divers programmes ont été lancés pour sensibiliser à l'utilisation appropriée des injectables d'acide hyaluronique.

La prise de conscience accrue permettra aux consommateurs d'opter pour le traitement approprié de l'acné et des rides et de sélectionner le bon produit (injection de Botox, produits de comblement dermique) en fonction de la cause. Cela entraînera une augmentation des ventes, une augmentation du portefeuille de produits et une extension de la gamme de produits. Ce facteur devrait propulser la croissance du marché.

  • Utilisation de produits de comblement cutané invasifs à base d'acide hyaluronique

Les produits de comblement dermique à base d'acide hyaluronique sont des procédés cosmétiques moins invasifs, qui se multiplient rapidement dans le monde entier. Il s'agit de procédures cosmétiques populaires pour la rénovation du visage, la restauration du volume du visage et l'amélioration esthétique.

Ils sont très polyvalents et sont utilisés sur les ridules et les rides. En outre, ils sont également utilisés pour traiter l'acné, les rides et les cicatrices et pour l'augmentation des lèvres, des joues et du menton. L'augmentation de la population gériatrique a accru la nécessité de protocoles chirurgicaux non invasifs.

L'utilisation de produits de comblement à base d'acide hyaluronique réduira les chances de recourir à la chirurgie classique. Le coût du traitement est minime et ce facteur stimulera la croissance du marché.

RESTRICTIONS

  • La disponibilité de produits de comblement cutané non autorisés ou alternatifs pourrait entraver le marché

Avec l’accessibilité généralisée de l’application esthétique des produits de comblement dermique à base d’acide hyaluronique, plusieurs facteurs limitatifs de ces produits devraient entraver la croissance du marché du Moyen-Orient et de l’Afrique dans les années à venir.

En raison de son taux d'efficacité élevé, de la satisfaction des patients et de son utilisation dans les rides dynamiques, le type de toxine botulique, un produit de comblement dermique, est leader dans le domaine des procédures cosmétiques non chirurgicales dans le monde entier.

De plus, d’autres charges biodégradables, telles que l’hydroxyapatite de calcium (CaHA) et l’acide poly-L-latique, gagnent en popularité en tant que charges alternatives utilisées comme implants avec une longévité élevée.

Les médecins sont réticents à utiliser des produits illégaux à bas prix, en raison des risques qu'ils comportent. À l'inverse, les produits illégaux disponibles dans le segment des produits de comblement dermique vont accroître la concurrence sur les prix, en particulier dans le segment de l'acide hyaluronique. Les grandes entreprises qui proposent des prix unitaires élevés ont la capacité de rivaliser en proposant plusieurs offres groupées de produits et en vendant des produits dans différentes divisions de produits.

Pour compenser la baisse des prix des produits de comblement à base d'acide hyaluronique, les fabricants de particules et de polymères devront promouvoir leurs produits. Les produits disponibles dans ce segment varient. Les fabricants se concentreront davantage sur la résistance du matériau utilisé dans les produits de comblement plutôt que sur le prix de revient.

OPPORTUNITÉS

  • Nouvelles technologies et développements dans les produits à base d'acide hyaluronique

Les technologies innovantes avancées ont amélioré le traitement esthétique de la peau et d'autres parties du corps partout où cela est nécessaire et l'industrie des soins de la peau est l'une de celles qui évoluent le plus rapidement. Les marques locales proposant des actifs, des soins de la peau à base d'ingrédients et le secteur de la beauté connaissent une augmentation des investissements et le consommateur est vivement impliqué. La technologie innovante avancée et les développements des produits à base d'acide hyaluronique stimulent la demande d'acide hyaluronique sur le marché.

Les produits dermiques à base d'acide hyaluronique sont à base d'acide hyaluronique qui corrige les imperfections du visage, compense le volume et met en valeur certaines zones du visage. Les progrès réalisés dans le domaine des produits dermiques offrent un moyen efficace d'améliorer, de restaurer et de définir les traits du visage. Les progrès réalisés dans le domaine des produits à base d'acide hyaluronique et des procédures de comblement dermique attirent les clients vers les cosmétiques. Ainsi, cela signifie que les progrès technologiques dans le domaine des produits dermiques à base d'acide hyaluronique devraient constituer une opportunité de croissance du marché.

DÉFIS

  • Rappel de produit progressif

Le rappel des produits à base d'acide hyaluronique a eu un impact considérable sur la croissance du marché. Les autorités réglementaires rappellent les produits esthétiques et cosmétiques en raison de problèmes de santé et de sécurité. Chaque pays dispose de sa propre autorité de réglementation chargée de surveiller la réglementation des produits liés aux soins de santé.

Le rappel de produits par les entreprises ou par les autorités réglementaires pour des raisons de sécurité sanitaire des patients, telles que l'inexactitude du contenu ou une erreur d'ingrédient, sont quelques-unes des principales préoccupations qui constituent un défi à la croissance du marché, car la sécurité et la santé des patients sont les critères les plus importants pour tout marché introduisant ses produits sur le marché.

Développements récents

  • En février 2022, Allergan (une filiale d'AbbVie Inc.) a annoncé l'approbation par la FDA de JUVÉDERM VOLBELLA XC pour l'amélioration des creux infraorbitaires chez les adultes de plus de 21 ans. Cela a aidé l'entreprise à élargir son portefeuille de produits esthétiques sur le marché américain.
  • En février 2021, Contipro, un fabricant renommé d'acide hyaluronique basé en République tchèque, a annoncé le lancement de son nouveau produit de traitement anti-âge et anti-acné appelé HyRetin, qui améliore la visibilité de la peau.

Portée du marché de l'acide hyaluronique au Moyen-Orient et en Afrique

Le marché de l'acide hyaluronique au Moyen-Orient et en Afrique est segmenté en cinq segments notables en fonction de la qualité, du type, de l'application, de l'utilisateur final et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance maigres dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour prendre des décisions stratégiques afin d'identifier les principales applications du marché.

Grade

  • Qualité cosmétique
  • Qualité pharmaceutique

En fonction de la qualité, le marché est segmenté en qualité cosmétique et qualité pharmaceutique.

Taper

  • Acide hyaluronique hydrolysé
  • Acide hyaluronique acétylé de sodium
  • Hyaluronate de sodium

En fonction du type, le marché est segmenté en acide hyaluronique hydrolysé, acide hyaluronique acétylé de sodium et hyaluronate de sodium.

Application

  • Esthétique
  • Arthrose
  • API pharmaceutique
  • Produits de beauté
  • Ophtalmologie
  • Autres

En fonction des applications, le marché est segmenté en esthétique, arthrose, API pharmaceutiques, cosmétiques, ophtalmologie et autres.

Utilisateur final

  • Industrie pharmaceutique
  • Cliniques de dermatologie
  • Centres de chirurgie esthétique
  • Autres

En fonction de l’utilisateur final, le marché est segmenté en industrie pharmaceutique, cliniques de dermatologie, centres de chirurgie esthétique et autres.

Canal de distribution

  • Appel d'offres direct
  • Ventes au détail

En fonction du canal de distribution, le marché est segmenté en ventes directes et ventes au détail.

Analyse/perspectives régionales du marché de l'acide hyaluronique au Moyen-Orient et en Afrique   

Le marché de l’acide hyaluronique au Moyen-Orient et en Afrique est analysé et des informations et tendances sur la taille du marché sont fournies par pays, qualité, type, application, utilisateur final et canal de distribution comme référencé ci-dessus.

Les pays couverts dans ce rapport de marché sont l’Afrique du Sud, l’Arabie saoudite, les Émirats arabes unis, l’Égypte, Israël et le reste du Moyen-Orient et de l’Afrique.

  • In 2023, South Africa is dominating the Middle East and Africa hyaluronic acid market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to a rise in product approvals.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and their challenges faced due to competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Hyaluronic Acid Market Share Analysis

The Middle East and Africa hyaluronic acid market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the Middle East and Africa hyaluronic acid market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 GRADE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES

4.4 INDUSTRY INSIGHTS

5 REGULATORY FRAMEWORK

5.1 EGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN EUROPE

5.3 REGULATORY SCENARIO IN CHINA

5.4 REGULATORY SCENARIO IN AUSTRALIA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS

6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES

6.2 RESTRAINTS

6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET

6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES

6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION

6.3 OPPORTUNITIES

6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS

6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT

6.4 CHALLENGES

6.4.1 ESCALATING PRODUCT RECALL

6.4.2 LACK OF EXPERTISE

7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE

7.1 OVERVIEW

7.2 COSMETIC GRADE

7.2.1 GENDER

7.2.1.1 FEMALE PRODUCTS

7.2.1.2 MEN’S PRODUCT

7.2.2 PRODUCT TYPE

7.2.2.1 SKIN CARE

7.2.2.2 MAKEUP

7.2.2.3 CLEANSING

7.2.2.4 HAIR CARE

7.2.2.5 OTHERS

7.2.3 PROCEDURE

7.2.3.1 WRINKLE REMOVAL

7.2.3.2 SKIN SMOOTHENING

7.2.3.3 FACE LIFT

7.2.3.4 LIP AUGMENTATION

7.2.3.5 CHIN AUGMENTATION

7.2.3.6 FAT INJECTION

7.2.3.7 FACE LINE CORRECTION

7.2.3.8 ACNE SCAR TREATMENT

7.2.3.9 LIP PLUM

7.2.3.10 EAR LOBE REJUVENATION

7.2.3.11 LIPOATROPHY TREATMENT

7.2.3.12 OTHERS

7.3 PHARMACEUTICAL GRADE

7.3.1 TYPE

7.3.1.1 MEDICAL GRADE HYALURONIC ACID

7.3.1.2 INJECTION GRADE HYALURONIC ACID

7.3.2 PRODUCT TYPE

7.3.2.1 TOPICAL PREPARATIONS

7.3.2.2 INTRA-ARTICULAR INJECTION

7.3.2.2.1 PREFILLED INJECTIONS

7.3.2.2.2 VIAL

7.3.2.3 EYE DROPS

7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS

7.3.2.5 OTHERS

8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE

8.1 OVERVIEW

8.2 SODIUM HYALURONATE

8.2.1 MOLECULAR WEIGHT

8.2.1.1 HIGH MOLECULAR WEIGHT

8.2.1.2 LOW MOLECULAR WEIGHT

8.2.1.3 MEDIUM MOLECULAR WEIGHT

8.2.2 BY TYPE

8.2.2.1 COSMETIC GRADE

8.2.2.1.1 GENDER

8.2.2.1.1.1 FEMALE PRODUCTS

8.2.2.1.1.2 MEN'S PRODUCT

8.2.2.1.2 PRODUCT TYPE

8.2.2.1.2.1 SKIN CARE

8.2.2.1.2.2 MAKEUP

8.2.2.1.2.3 CLEANSING

8.2.2.1.2.4 HAIR CARE

8.2.2.1.2.5 OTHERS

8.2.2.2 PHARMACEUTICAL GRADE

8.2.2.2.1 TYPE

8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.2.2.2.2 PRODUCT TYPE

8.2.2.2.2.1 TOPICAL PREPARATIONS

8.2.2.2.2.2 INTRA-ARTICULAR INJECTION

8.2.2.2.2.2.1 PREFILLED INJECTIONS

8.2.2.2.2.2.2 VIAL

8.2.2.2.2.3 EYE DROPS

8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.2.2.2.2.5 OTHERS

8.3 HYDROLYZED HYALURONIC ACID

8.3.1 MOLECULAR WEIGHT

8.3.1.1 HIGH MOLECULAR WEIGHT

8.3.1.2 LOW MOLECULAR WEIGHT

8.3.1.3 MEDIUM MOLECULAR WEIGHT

8.3.2 BY TYPE

8.3.2.1 COSMETIC GRADE

8.3.2.1.1 GENDER

8.3.2.1.1.1 FEMALE PRODUCTS

8.3.2.1.1.2 MEN'S PRODUCT

8.3.2.1.2 PRODUCT TYPE

8.3.2.1.2.1 SKIN CARE

8.3.2.1.2.2 MAKEUP

8.3.2.1.2.3 CLEANSING

8.3.2.1.2.4 HAIR CARE

8.3.2.1.2.5 OTHERS

8.3.2.2 PHARMACEUTICAL GRADE

8.3.2.2.1 TYPE

8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.3.2.2.2 PRODUCT TYPE

8.3.2.2.2.1 TOPICAL PREPARATIONS

8.3.2.2.2.2 INTRA-ARTICULAR INJECTION

8.3.2.2.2.2.1 PREFILLED INJECTIONS

8.3.2.2.2.2.2 VIAL

8.3.2.2.2.3 EYE DROPS

8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.3.2.2.2.5 OTHERS

8.4 SODIUM ACETYLATED HYALURONIC ACID

8.4.1 MOLECULAR WEIGHT

8.4.1.1 HIGH MOLECULAR WEIGHT

8.4.1.2 LOW MOLECULAR WEIGHT

8.4.1.3 MEDIUM MOLECULAR WEIGHT

8.4.2 BY TYPE

8.4.2.1 COSMETIC GRADE

8.4.2.1.1 GENDER

8.4.2.1.1.1 FEMALE PRODUCTS

8.4.2.1.1.2 MEN'S PRODUCT

8.4.2.1.2 PRODUCT TYPE

8.4.2.1.2.1 SKIN CARE

8.4.2.1.2.2 MAKEUP

8.4.2.1.2.3 CLEANSING

8.4.2.1.2.4 HAIR CARE

8.4.2.1.2.5 OTHERS

8.4.2.2 PHARMACEUTICAL GRADE

8.4.2.2.1 TYPE

8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.4.2.2.2 PRODUCT TYPE

8.4.2.2.2.1 TOPICAL PREPARATIONS

8.4.2.2.2.2 INTRA-ARTICULAR INJECTION

8.4.2.2.2.2.1 PREFILLED INJECTIONS

8.4.2.2.2.2.2 VIAL

8.4.2.2.2.3 EYE DROPS

8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.4.2.2.2.5 OTHERS

9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 AESTHETICS

9.3 OSTEOARTHRITIS

9.4 COSMETICS

9.5 OPHTHALMOLOGY

9.6 PHARMACEUTICAL API

9.7 OTHERS

10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER

10.1 OVERVIEW

10.2 DERMATOLOGY CLINICS

10.3 COSMETIC SURGERY CENTERS

10.4 MEDICAL SPAS AND BEAUTY CENTERS

10.5 OTHERS

11 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL PHARMACY

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY REGION

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 SAUDI ARABIA

12.1.3 U.A.E.

12.1.4 EGYPT

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 FIDIA FARMACEUTICI S.P.A. (2022)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ABBVIE INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 GALDERMA

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 LG CHEM (2022)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ABBOTT (2022)

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ANIKA THERAPEUTICS, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 COMPANY SHARE ANALYSIS

15.7.4 PRODUCT PORTFOLIO

15.7.5 RECENT DEVELOPMENTS

15.8 BIOSCIENCE GMBH

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIOXIS PHARMACEUTICALS

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BIOIBERICA S.A.U

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BOHUS BIOTECH AB

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BRICKELL MEN'S PRODUCTS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CONTIPRO A.S.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 FILLMED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GENESIS

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 HUONS

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 KEWPIE CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 LIFECORE BIOMEDICAL, INC.(2022)

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 PROLLENIUM MEDICAL TECHNOLOGIES

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 RIVER PHARMA S.R.L.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 SYMATESE

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 TEOXANE

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 VIRCHOW BIOTECH

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

Liste des tableaux

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 SOUTH AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 SOUTH AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 SOUTH AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 SOUTH AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 SOUTH AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 SOUTH AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 SAUDI ARABIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 SAUDI ARABIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 SAUDI ARABIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 SAUDI ARABIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 SAUDI ARABIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 SAUDI ARABIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 U.A.E. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 U.A.E. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 U.A.E. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 U.A.E. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 U.A.E. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 U.A.E. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 U.A.E. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 EGYPT HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 219 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 220 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 222 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 223 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 224 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 225 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 226 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 227 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 228 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 229 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 230 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 231 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 232 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 233 EGYPT HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 234 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 235 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 236 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 237 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 238 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 239 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 240 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 241 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 242 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 243 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 244 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 245 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 246 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 247 EGYPT INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 248 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 249 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 250 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 251 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 253 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 255 EGYPT HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 256 EGYPT HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 EGYPT HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 258 EGYPT RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 259 ISRAEL HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 260 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 261 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 263 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 264 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 265 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 266 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 267 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 268 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 270 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 271 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 273 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 274 ISRAEL HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 275 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 276 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 277 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 278 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 279 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 280 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 282 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 283 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 284 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 285 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 286 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 288 ISRAEL INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 289 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 290 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 291 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 292 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 293 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 294 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 ISRAEL HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 ISRAEL HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 298 ISRAEL HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 299 ISRAEL RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 300 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

Liste des figures

FIGURE 1 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DBMR POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

FIGURE 14 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2022

FIGURE 15 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)

FIGURE 17 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2022

FIGURE 19 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 21 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2022

FIGURE 23 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2022

FIGURE 27 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: SNAPSHOT (2022)

FIGURE 35 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022)

FIGURE 36 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: GRADE (2023-2030)

FIGURE 39 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Middle East and Africa Hyaluronic Acid Market is projected to grow at a CAGR of 5.7% during the forecast period by 2030.
The future market value of the Middle East and Africa Hyaluronic Acid Market is expected to reach USD 409.69 million by 2030.
The major players in the Middle East and Africa Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the Middle East and Africa Hyaluronic Acid Market are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.
Testimonial